BICLUSTER_ID : UPREG-108
PATHOGENS /3/ : yersinia enterocolitica,shigella dysenteriae,ehrlichia chaffeensis
TARGETS /12/ : ANXA1, JUN, HSPA1B, CCL2, CYP1B1, PTGS2, SAT1, IFNG, IL1R1, TNF, HSPA1A, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 4 PATHWAY UPFGL2, ANXA1, MXD1, REL, JUN, SCGB3A1, CCL2, CH25H, IL10, SOCS3, CYP1B1, RIPK2, IFNG, EGR2, TNC
GERY CEBP TARGETSGADD45B, CXCL1, HSPA1B, JUNB, GADD45G, RGS16, ATF3, SAT1, HSPA1A, PLAUR
NETPATH IL 2 PATHWAY UPJUN, SOCS3, CCL4, IER3, IFIT1, FUBP1, KLF6, CSF1, GADD45G, TRIM21, CCR1, RGS1, PBEF1, DAXX, IL1R1, PLAUR, TNF
NETPATH IL 1 PATHWAY UPRHOB, JUN, CXCL1, CCL2, CHI3L1, PTGS2, PBEF1, MT2A, CXCL2, CCL4
NETPATH IL 3 PATHWAY UPSOCS3, CSF1, CCL2, TNF, CCL4
NETPATH IL 6 PATHWAY UPSOCS3, MAFF, GADD45B, CXCL1, JUN, JUNB, MAP3K8, TNF
NETPATH IL 9 PATHWAY UPSOCS3, CCL2, JUNB
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CXCL2, CCL4
NETPATH IL 5 PATHWAY UPNFKBIB, LCP2, PLSCR1, REL, CCL2, IER3, CASP4, EGR2
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
LENAOUR DENDRITIC CELL MATURATION UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
LINDGREN BLADDER CANCER CLUSTER 2B
VARELA ZMPSTE24 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
RASHI RESPONSE TO IONIZING RADIATION 2
HUANG FOXA2 TARGETS DN
LINDSTEDT DENDRITIC CELL MATURATION A
BASAKI YBX1 TARGETS DN
ELVIDGE HYPOXIA UP
AMIT EGF RESPONSE 40 HELA
NETPATH TGFBETA RECEPTOR PATHWAY UP
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
PAL PRMT5 TARGETS DN
DELYS THYROID CANCER UP
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
KORKOLA TERATOMA
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
MCLACHLAN DENTAL CARIES UP
GAJATE RESPONSE TO TRABECTEDIN UP
NEWMAN ERCC6 TARGETS UP
PODAR RESPONSE TO ADAPHOSTIN UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
KERLEY RESPONSE TO CISPLATIN UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
NCI IL23PATHWAY
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
BERENJENO TRANSFORMED BY RHOA UP
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
NCI P53DOWNSTREAMPATHWAY
SPIRA SMOKERS LUNG CANCER UP
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
HUANG DASATINIB RESISTANCE UP
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
WONG ENDMETRIUM CANCER DN
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
LEONARD HYPOXIA
CHEN LVAD SUPPORT OF FAILING HEART DN
KEGG ASTHMA
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
SA MMP CYTOKINE CONNECTION
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
BOYLAN MULTIPLE MYELOMA C DN
BIOCARTA CCR5 PATHWAY
SAGIV CD24 TARGETS DN
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
HORIUCHI WTAP TARGETS UP
ONDER CDH1 SIGNALING VIA CTNNB1
WOO LIVER CANCER RECURRENCE UP
NETPATH IL 4 PATHWAY DOWN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
MAHADEVAN RESPONSE TO MP470 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
RIGGI EWING SARCOMA PROGENITOR UP
BROWNE HCMV INFECTION 30MIN UP
MCCABE HOXC6 TARGETS DN
BUDHU LIVER CANCER METASTASIS DN
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
RUIZ TNC TARGETS DN
SEIKE LUNG CANCER POOR SURVIVAL
AMIT EGF RESPONSE 20 HELA
SANA TNF SIGNALING DN
MUELLER METHYLATED IN GLIOBLASTOMA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
CHANG POU5F1 TARGETS UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
NCI PTP1BPATHWAY
FRIDMAN SENESCENCE UP
NCI PROSTANOID HORMONES
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
RIGGI EWING SARCOMA PROGENITOR DN
WANG ESOPHAGUS CANCER PROGRESSION UP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
MARKS HDAC TARGETS DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
MCLACHLAN DENTAL CARIES DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
LEE RECENT THYMIC EMIGRANT
BIERIE INFLAMMATORY RESPONSE TGFB1
ENGELMANN CANCER PROGENITORS UP
SANA TNF SIGNALING UP
SENESE HDAC1 AND HDAC2 TARGETS UP
XU HGF TARGETS INDUCED BY AKT1 6HR
SENESE HDAC1 TARGETS UP
MAINA VHL TARGETS DN
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
JISON SICKLE CELL DISEASE UP
BIOCARTA GRANULOCYTES PATHWAY
HESS TARGETS OF HOXA9 AND MEIS1 DN
TARTE PLASMA CELL VS PLASMABLAST UP
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
NETPATH T CELL RECEPTOR PATHWAY UP
IIZUKA RECURRENT LIVER CANCER
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
CROONQUIST NRAS VS STROMAL STIMULATION DN
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
CORUM ETS2-FOS-JUN COMPLEX
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansayersinia enterocolitica p60 bl6shigella dysenteriaeGeneSet Name
0.00011 0.00010 0.01729NETPATH_IL_4_PATHWAY_UP
0.01308 0.00040 0.00067GERY_CEBP_TARGETS
0.00029 0.00994 0.08636NETPATH_IL_2_PATHWAY_UP
0.00744 0.00000 0.00030NETPATH_IL_1_PATHWAY_UP
0.00000 0.00000 0.00147NETPATH_IL_3_PATHWAY_UP
0.00003 0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.00097 0.00016 0.05058NETPATH_IL_9_PATHWAY_UP
0.00034 0.00709 0.04120NETPATH_IL_7_PATHWAY_UP
0.00007 0.00711 0.00014NETPATH_IL_5_PATHWAY_UP
0.00082 0.00108 0.19139BIOCARTA_IL10_PATHWAY
0.00021 0.00021 0.00252GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.16432 0.01129 0.09817LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.06659 0.05121 0.01398BIOCARTA_NFKB_PATHWAY
0.01198 0.00010 0.00316MAHAJAN_RESPONSE_TO_IL1A_UP
0.00000 0.01562 0.18538LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.05834 0.15490 0.00166VARELA_ZMPSTE24_TARGETS_UP
0.14628 0.00019 0.00017CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00000 0.04211 0.08527TENEDINI_MEGAKARYOCYTE_MARKERS
0.00007 0.04591 0.00053LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.17481 0.00114 0.00825BIOCARTA_IL1R_PATHWAY
0.03916 0.00042 0.17115SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00307 0.00297 0.00004RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.09364 0.02841 0.17483HUANG_FOXA2_TARGETS_DN
0.00000 0.00029 0.00034LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.15013 0.16659 0.17420BASAKI_YBX1_TARGETS_DN
0.01170 0.00031 0.00124ELVIDGE_HYPOXIA_UP
0.03874 0.00021 0.00000AMIT_EGF_RESPONSE_40_HELA
0.18277 0.05939 0.09633NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.00076 0.10787 0.00016MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.00155 0.04032 0.00317MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.12490 0.11861 0.03553AMIT_EGF_RESPONSE_480_HELA
0.00046 0.01900 0.02542JEON_SMAD6_TARGETS_UP
0.01384 0.00184 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.04656 0.01867 0.11110TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00017 0.12093 0.04937BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00055 0.00000 0.00078HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00000 0.01647 0.14227MARKEY_RB1_ACUTE_LOF_UP
0.00013 0.00058 0.00096KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.12062 0.01826 0.03970XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.00001 0.08169 0.01483OSADA_ASCL1_TARGETS_DN
0.00475 0.00356 0.08521NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00201 0.02611DUTTA_APOPTOSIS_VIA_NFKB
0.01020 0.05425 0.02795PAL_PRMT5_TARGETS_DN
0.00020 0.05105 0.12700DELYS_THYROID_CANCER_UP
0.00678 0.13887 0.01869KRISHNAN_FURIN_TARGETS_UP
0.00000 0.00018 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.01711 0.02147 0.14554RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.04507 0.02158 0.00093KORKOLA_TERATOMA
0.00000 0.00012 0.17156REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.03630 0.15482 0.00077NCI_NFAT_TFPATHWAY
0.01092 0.00000 0.00006ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00123 0.06839 0.02436RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.07404 0.00029 0.00113AMIT_EGF_RESPONSE_120_HELA
0.00130 0.06859 0.18421DANG_REGULATED_BY_MYC_DN
0.01021 0.10917 0.13279NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.11984 0.01519 0.04655WINTER_HYPOXIA_METAGENE
0.00000 0.00050 0.01598MCLACHLAN_DENTAL_CARIES_UP
0.02606 0.02695 0.10594GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00936 0.03258 0.08581NEWMAN_ERCC6_TARGETS_UP
0.00428 0.00000 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.13511 0.07034 0.04735CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.00572 0.06979 0.00349TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.00236FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.04466GAURNIER_PSMD4_TARGETS
0.06718 0.12090 0.16070KERLEY_RESPONSE_TO_CISPLATIN_UP
0.02810 0.00980 0.00666SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.04059 0.17984 0.07626NETPATH_TNF_ALPHA_PATHWAY_UP
0.00000 0.00000 0.09953NCI_IL23PATHWAY
0.00269 0.00000 0.03754ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00047 0.00000 0.00000GESERICK_TERT_TARGETS_DN
0.00573 0.01777 0.19222NOJIMA_SFRP2_TARGETS_DN
0.05857 0.06583 0.11137NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.04018 0.00007 0.00021AMIT_SERUM_RESPONSE_120_MCF10A
0.15614 0.00222 0.00008BROWNE_HCMV_INFECTION_2HR_UP
0.09965 0.06247 0.12456BERENJENO_TRANSFORMED_BY_RHOA_UP
0.17152 0.00078 0.00000SESTO_RESPONSE_TO_UV_C3
0.00000 0.00000 0.00095VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.06408 0.05158 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.00000 0.04624 0.00055BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00175 0.00109 0.01687GEISS_RESPONSE_TO_DSRNA_UP
0.07476 0.11365 0.01375NCI_P53DOWNSTREAMPATHWAY
0.11439 0.04515 0.00833SPIRA_SMOKERS_LUNG_CANCER_UP
0.07185 0.00240 0.07953BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.09979 0.00000 0.01029ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.15171 0.07095 0.00141CHASSOT_SKIN_WOUND
0.00003 0.00016 0.00005TIAN_TNF_SIGNALING_VIA_NFKB
0.01775 0.17945 0.00000KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00021 0.00058 0.00154LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.11440 0.06744 0.00000AMIT_DELAYED_EARLY_GENES
0.00143 0.00029 0.16166HUANG_DASATINIB_RESISTANCE_UP
0.02646 0.00000 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00358 0.00034 0.00153HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.05028 0.09943 0.14629WONG_ENDMETRIUM_CANCER_DN
0.00610 0.19873 0.04471RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.01772 0.00037 0.00035NOJIMA_SFRP2_TARGETS_UP
0.00013 0.00176 0.18018CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.01170 0.01499 0.00221CHEN_HOXA5_TARGETS_6HR_UP
0.00123 0.00038 0.00484MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00021 0.02220 0.05182SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00488 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.02314 0.05363 0.00000NCI_ATF2_PATHWAY
0.01232 0.01346 0.01701LEONARD_HYPOXIA
0.04644 0.16613 0.18395CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.06161 0.02752 0.19147KEGG_ASTHMA
0.16308 0.01204 0.19068SESTO_RESPONSE_TO_UV_C1
0.00000 0.00954 0.00808CROONQUIST_STROMAL_STIMULATION_UP
0.00037 0.01474 0.10485SA_MMP_CYTOKINE_CONNECTION
0.00044 0.00258 0.02359BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.03101 0.00022 0.00005HALMOS_CEBPA_TARGETS_UP
0.01150 0.00037 0.17065WU_CELL_MIGRATION
0.18326 0.04754 0.02535BOYLAN_MULTIPLE_MYELOMA_C_DN
0.12123 0.10323 0.01069BIOCARTA_CCR5_PATHWAY
0.00127 0.18844 0.01026SAGIV_CD24_TARGETS_DN
0.00000 0.05355 0.00741KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00000 0.03216 0.07873KIM_LRRC3B_TARGETS
0.00147 0.01137 0.00236HORIUCHI_WTAP_TARGETS_UP
0.05380 0.03049 0.01233ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.00000 0.00424 0.05864WOO_LIVER_CANCER_RECURRENCE_UP
0.00001 0.00146 0.16501NETPATH_IL_4_PATHWAY_DOWN
0.15904 0.03385 0.15816GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.06062 0.07122 0.05696ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.00000 0.13271 0.01423RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.18500 0.00072 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.00000 0.00504 0.00072CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.04066 0.00782 0.14472RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.00262 0.10027 0.00103BROWNE_HCMV_INFECTION_30MIN_UP
0.04804 0.10115 0.06262MCCABE_HOXC6_TARGETS_DN
0.01307 0.02833 0.10833BUDHU_LIVER_CANCER_METASTASIS_DN
0.00160 0.00029 0.00501HARRIS_HYPOXIA
0.02531 0.00015 0.00112NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.02263 0.18893FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00144 0.02538 0.00000DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.01714 0.02559 0.00304CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00614 0.01586 0.15051RUIZ_TNC_TARGETS_DN
0.01151 0.00934 0.08149SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00013 0.18824 0.00013AMIT_EGF_RESPONSE_20_HELA
0.06640 0.06271 0.08928SANA_TNF_SIGNALING_DN
0.01499 0.08747 0.13134MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.09168 0.00165 0.02489KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.00018 0.00004BASSO_CD40_SIGNALING_UP
0.07456 0.13956 0.11403CHANG_POU5F1_TARGETS_UP
0.09628 0.00683 0.00005TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00648 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00161 0.00021 0.00321MARZEC_IL2_SIGNALING_UP
0.00003 0.00018 0.02047SOUCEK_MYC_TARGETS
0.17707 0.00000 0.11301TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.07345 0.05840 0.07968ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00034 0.00270 0.00008BILBAN_B_CLL_LPL_DN
0.00434 0.03028 0.12426WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.09080 0.10130 0.09041NCI_PTP1BPATHWAY
0.00696 0.17993 0.08918FRIDMAN_SENESCENCE_UP
0.01960 0.19314 0.06968NCI_PROSTANOID_HORMONES
0.00029 0.00018 0.06328MAHADEVAN_RESPONSE_TO_MP470_UP
0.00947 0.01472 0.00712FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00696 0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00001 0.00000 0.00396LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.06189 0.00005DAUER_STAT3_TARGETS_UP
0.06898 0.00000 0.06512ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.07814 0.00317KEGG_LEISHMANIA_INFECTION
0.17486 0.03905 0.02949RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.08841 0.02833 0.02346WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.05909 0.00019 0.00007AMIT_EGF_RESPONSE_60_HELA
0.02809 0.08832 0.00827ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00705 0.00332 0.00170BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.06022 0.02398 0.08234MARKS_HDAC_TARGETS_DN
0.01709 0.00807 0.00000CHEN_HOXA5_TARGETS_9HR_UP
0.03944 0.01250 0.00032DAZARD_UV_RESPONSE_CLUSTER_G2
0.00000 0.00065 0.02949MCLACHLAN_DENTAL_CARIES_DN
0.00705 0.00000 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.11721 0.00993 0.00236HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00007 0.00398 0.00003GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.06066 0.00489 0.00146CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00208 0.03654 0.14727LEE_RECENT_THYMIC_EMIGRANT
0.03251 0.05248 0.05553BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.03879 0.10778 0.12755ENGELMANN_CANCER_PROGENITORS_UP
0.00000 0.00022 0.00530SANA_TNF_SIGNALING_UP
0.15854 0.01129 0.00255SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.03408 0.02501 0.07814XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.09820 0.01901 0.02245SENESE_HDAC1_TARGETS_UP
0.08042 0.16597 0.15703MAINA_VHL_TARGETS_DN
0.02186 0.06039 0.10402INGA_TP53_TARGETS
0.00262 0.00030 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.13365 0.00039 0.00000KIM_WT1_TARGETS_UP
0.09963 0.00979 0.02950SENESE_HDAC3_TARGETS_UP
0.02814 0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00000 0.06359 0.07115JISON_SICKLE_CELL_DISEASE_UP
0.00024 0.01449 0.18726BIOCARTA_GRANULOCYTES_PATHWAY
0.00000 0.00006 0.00054HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00932 0.12694 0.04650TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.14492 0.00177 0.00099DASU_IL6_SIGNALING_UP
0.04510 0.00028 0.00078ELVIDGE_HYPOXIA_BY_DMOG_UP
0.01014 0.18828 0.15288NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.00929 0.09789 0.12265IIZUKA_RECURRENT_LIVER_CANCER
0.00001 0.00037 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00087 0.04783 0.02426CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.05925 0.08058 0.05947GOUYER_TATI_TARGETS_UP
0.00511 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.10538 0.04370 0.00013ZUCCHI_METASTASIS_DN
0.01712 0.04754 0.10389RUTELLA_RESPONSE_TO_HGF_UP
0.07569 0.02844 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00144 0.01530 0.00132WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.05509 0.09254 0.14136CORUM_ETS2-FOS-JUN_COMPLEX
0.05114 0.00000 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.18992 0.14239 0.03633YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1